# TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS

> **NIH NIH N01** · UNIVERSITY OF ALABAMA AT BIRMINGHAM · 2021 · $2,579,355

## Abstract

To advance the development of therapeutic strategies for rare and/or emerging viral diseases of medical importance in targeted patient populations by 1) characterizing contemporary course of the clinical disease, and/or 2) directly evaluating a therapy.

## Key facts

- **NIH application ID:** 10474939
- **Project number:** 272201600017C-P00007-9999-1
- **Recipient organization:** UNIVERSITY OF ALABAMA AT BIRMINGHAM
- **Principal Investigator:** DAVID KIMBERLIN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $2,579,355
- **Award type:** —
- **Project period:** 2016-07-01 → 2026-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10474939

## Citation

> US National Institutes of Health, RePORTER application 10474939, TARGETED CLINICAL RESEARCH TO ADDRESS SELECT VIRAL INFECTIONS (272201600017C-P00007-9999-1). Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/grant/nih/10474939. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*